Fuda Cancer Hospital
Wilms tumor (nephroblastoma) treatment cost in China typically includes biochemical blood analysis from $100 to $100 and complex treatment of nephroblastoma ranging from Price on request to Price on request . Total expenses depend on the cancer stage, hospital tier, and therapeutic protocols. Families can expect 30-50% savings compared to the US. Top treatment centers are located in Guangzhou and Beijing.
Typical Wilms Tumor (Nephroblastoma) Treatment Costs in China
Bookimed Expert Insight: For advanced cases, multidisciplinary centers like Fuda Cancer Hospital offer specialized minimally invasive alternatives. Their oncologists utilize technologies like NanoKnife and cryosurgery for patients seeking options beyond traditional chemotherapy. This approach is best for complex or late-stage tumors. JCI-accredited facilities in China provide western-standard safety levels at competitive international rates. Multimodal protocols coordinate surgery and systemic therapy efficiently in one location.
| China | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Wilms tumor (Nephroblastoma) treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Wilms tumor (Nephroblastoma) treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Wilms tumor (Nephroblastoma) treatment journey.
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Top hospitals for pediatric Wilms tumor in China include the Beijing Children Hospital and Shanghai Children Medical Center. These facilities provide integrated care through multidisciplinary tumor boards. They utilize specialized pediatric oncology teams and surgeons to manage complex renal masses and advanced nephroblastoma cases effectively.
Bookimed Expert Insight: While public university hospitals in Beijing and Shanghai handle the highest case volumes, Fuda Cancer Hospital serves as a key private alternative. It has treated over 30,000 patients from 100 countries. For complex cases needing advanced ablation like NanoKnife or cryosurgery, this facility offers highly specialized technological access.
Patient Consensus: Families emphasize that pathology subtyping and lymph node sampling are critical for accurate staging. Many seek second opinions in Beijing or Shanghai before starting long-term chemotherapy locally.
Chinese oncologists treat Wilms tumor using a hybrid approach combining North American COG and European SIOP protocols. This strategy personalizes care based on tumor size and risk. Practitioners often prioritize upfront surgery for localized tumors. Advanced cases typically receive preoperative chemotherapy to reduce tumor volume.
Bookimed Expert Insight: JCI-accredited facilities like Fuda Cancer Hospital utilize over 10 types of minimally invasive therapies. While traditional protocols rely on systemic drugs, these advanced centers integrate vascular interventional therapy. This targeted approach is a useful regional bridge when massive tumors don't respond to standard systemic regimens.
Patient Consensus: Parents emphasize choosing high-volume pediatric centers to ensure specialized pathology reviews. They note that chemotherapy is almost always expected after surgery to prevent recurrence.
Advanced minimally invasive surgeries for children with Wilms tumor are available in China. Specialized pediatric oncology teams perform laparoscopic and robot-assisted nephrectomies at JCI-accredited centers in cities like Guangzhou. These procedures utilize 3D magnification to ensure high precision during tumor removal.
Bookimed Expert Insight: While many facilities market diverse minimally invasive therapies, look specifically for clinics with JCI accreditation like Fuda Cancer Hospital. These institutions often handle high volumes of international patients. Our data indicates that late-stage cases may require vascular interventional therapy alongside standard surgery. This combination is often more effective than traditional methods alone for complex pediatric solid tumors.
Patient Consensus: Parents note that a clean open operation is often safer than a rushed robotic approach. They emphasize choosing surgeons based on their specific experience with pediatric renal tumor case volumes.
Hospitals do not offer immunotherapy or CAR-T cell therapy as standard treatment for relapsed Wilms tumor. These therapies are currently available only through specialized clinical trials. Most centers prioritize multi-modal salvage approaches. Standard protocols include high-dose chemotherapy, radiation, and surgical resection.
Bookimed Expert Insight: China's oncology landscape for advanced cases often emphasizes specialized alternatives like NanoKnife or cryosurgery at JCI-accredited facilities like Fuda Cancer Hospital. While these are not immunotherapy, they provide options for advanced solid tumors when standard salvage chemotherapy is insufficient. Patients should confirm if a facility specifically handles pediatric nephroblastoma before traveling, as many advanced technology centers focus primarily on adult solid tumors.
Patient Consensus: Patients note that while hospitals may advertise immunotherapy, it often applies to other cancers rather than Wilms tumor. Families emphasize starting established salvage treatments immediately rather than delaying care to search for experimental CAR-T options.
Therapeutic options for relapsed or anaplastic Wilms tumor in China include intensified salvage chemotherapy and radical surgery. Advanced centers utilize autologous stem cell transplantation and targeted therapies. These protocols align with international COG and SIOP frameworks to manage aggressive histologies and chemoresistant cases.
Bookimed Expert Insight: While standard pediatric centers follow traditional protocols, JCI-accredited facilities like Fuda Cancer Hospital in Guangzhou specialize in minimally invasive alternatives. They offer technologies like NanoKnife and vascular interventional therapy for late-stage cases. This is particularly valuable for tumors near critical structures where aggressive surgery carries high risks.
Patient Consensus: Patients emphasize that treating anaplastic histology is significantly more intensive and longer than first-line therapy. Many recommend seeking a second pathology opinion at major academic hospitals to confirm the exact risk level before starting salvage regimens.
JCI-accredited cancer centers in China provide dedicated English-speaking international departments for families. Facilities like Fuda Cancer Hospital in Guangzhou have treated patients from 100 countries. They offer medical coordinators to assist with appointments, visa documentation, and clinical communication during Wilms tumor treatment.
Bookimed Expert Insight: While Fuda Cancer Hospital maintains a high 4.6 rating, English fluency varies across different hospital wards. Families benefit most when utilizing the international department specifically for translating complex pathology reports. Large private institutions in cities like Guangzhou typically offer more consistent English support than smaller local clinics.
Patient Consensus: Parents find that while coordinators speak English well, oncology teams may have limited medical fluency. Many families recommend requesting all lab values and medication lists in writing to avoid verbal misunderstandings during chemotherapy cycles.
Patients typically require 3 to 7 days of hospitalization for the surgical removal of a Wilms tumor. While surgery is brief, the total treatment cycle spans 4 to 34 weeks. This includes outpatient chemotherapy and radiation sessions rather than a single continuous hospital stay.
Bookimed Expert Insight: Fuda Cancer Hospital in Guangzhou offers over 10 types of minimally invasive therapies. These technologies often allow for shorter hospital stays compared to traditional open surgeries. While Fuda focuses on advanced cases, its JCI accreditation ensures that international safety standards are met. Families should budget for local housing rather than hospital beds to manage costs during outpatient chemotherapy.
Patient Consensus: Families should plan for several separate short stays instead of one long trip. Parents emphasize leaving extra time for pathology reviews and staging changes that might extend the visit.